Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiretroviral therapy |
| gptkbp:activeIngredient |
gptkb:tenofovir_disoproxil_fumarate
emtricitabine |
| gptkbp:administeredBy |
oral
|
| gptkbp:approvalYear |
2004
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AR03
|
| gptkbp:combinationTherapy |
yes
|
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Truvada
|
| gptkbp:indication |
post-exposure prophylaxis
pre-exposure prophylaxis HIV-1 infection |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Gilead_Sciences
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescribes |
adolescents
adults |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache renal impairment decreased bone mineral density |
| gptkbp:takenOnceDaily |
yes
|
| gptkbp:usedAs |
gptkb:PrEP
gptkb:EP |
| gptkbp:usedFor |
HIV prevention
HIV treatment |
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:Gilead_Sciences
gptkb:Gilead |
| gptkbp:bfsLayer |
5
|